Correlation Between Edgewise Therapeutics and MediciNova

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and MediciNova, you can compare the effects of market volatilities on Edgewise Therapeutics and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and MediciNova.

Diversification Opportunities for Edgewise Therapeutics and MediciNova

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Edgewise and MediciNova is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and MediciNova go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and MediciNova

Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the MediciNova. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 4.7 times less risky than MediciNova. The stock trades about -0.11 of its potential returns per unit of risk. The MediciNova is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  163.00  in MediciNova on August 28, 2024 and sell it today you would earn a total of  42.00  from holding MediciNova or generate 25.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Edgewise Therapeutics  vs.  MediciNova

 Performance 
       Timeline  
Edgewise Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
MediciNova 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.

Edgewise Therapeutics and MediciNova Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edgewise Therapeutics and MediciNova

The main advantage of trading using opposite Edgewise Therapeutics and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.
The idea behind Edgewise Therapeutics and MediciNova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Valuation
Check real value of public entities based on technical and fundamental data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals